Integration of “off label” drugs into standard and new cancer treatment regimens can potentiate treatments, extend duration of treatment response, mitigate adverse side effects and in some cases modify the disease course, halting cancer progression. “Off label” drugs taken from other indications, like treating high blood pressure or anxiety, can be tailored at specific dosages and combined with core treatments to generate positive synergistic effects and even as a stand-alone, in the future new line of FDCs will be proven to be an effective immune modulator as well, especially addressing ICI based drugs unmet needs.

​

ReInvent Pharma's revolutionary proprietary combination therapy is fortifying the fight against cancer and changing the landscape of cancer treatment by making new technologies, such as immune and targeted, more effective and affordable. Our technology is data driven; based on our own in-house studies and published data. Learn more about drug repurposing methodologies from selected medical journals below and reach out to us if you have a publication or idea to share.